|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
First published online July 12, 2005
doi: 10.1242/10.1242/jcs.02421
Research Article |

1 Faculty of Life Sciences, University of Manchester, Manchester, M13 9PT, UK
2 Department of Biological Sciences, Imperial College, London, SW7 2AS, UK
Author for correspondence (e-mail: philip.woodman{at}manchester.ac.uk, c.hopkins{at}imperial.ac.uk)
Accepted 6 April 2005
The early endosome comprises morphologically distinct regions specialised in sorting cargo receptors. A central question is whether receptors move through a predetermined structural pathway, or whether cargo selection contributes to the generation of endosome morphology and membrane flux. Here, we show that depletion of tumour susceptibility gene 101 impairs the selection of epidermal growth factor receptor away from recycling receptors within the limiting membrane of the early endosome. Consequently, epidermal growth factor receptor sorting to internal vesicles of the multivesicular body and cargo recycling to the cell surface or Golgi complex are inhibited. These defects are accompanied by disruption of bulk flow transport to the lysosome and profound structural rearrangement of the early endosome. The pattern of tubular and vacuolar domains is replaced by enlarged vacuoles, many of which are folded into multicisternal structures resembling the `Class E' compartments that define several Saccharomyces cerevisiae vacuolar protein sorting mutants. The cisternae are interleaved by a fine matrix but lack other surface elaborations, most notably clathrin.
Key words: endocytosis, multi-vescicular body (MVB), ESCRT, GFR, transferrin
Related articles in JCS:
This article has been cited by other articles:
![]() |
A. Doyotte, A. Mironov, E. McKenzie, and P. Woodman The Bro1-related protein HD-PTP/PTPN23 is required for endosomal cargo sorting and multivesicular body morphogenesis PNAS, April 29, 2008; 105(17): 6308 - 6313. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. G. Luttge, M. Shehu-Xhilaga, D. G. Demirov, C. S. Adamson, F. Soheilian, K. Nagashima, A. G. Stephen, R. J. Fisher, and E. O. Freed Molecular Characterization of Feline Immunodeficiency Virus Budding J. Virol., March 1, 2008; 82(5): 2106 - 2119. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Chatel-Chaix, L. Abrahamyan, C. Frechina, A. J. Mouland, and L. DesGroseillers The Host Protein Staufen1 Participates in Human Immunodeficiency Virus Type 1 Assembly in Live Cells by Influencing pr55Gag Multimerization J. Virol., June 15, 2007; 81(12): 6216 - 6230. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Y. Kim, J. A. Olzmann, G. S. Barsh, L.-S. Chin, and L. Li Spongiform Neurodegeneration-associated E3 Ligase Mahogunin Ubiquitylates TSG101 and Regulates Endosomal Trafficking Mol. Biol. Cell, April 1, 2007; 18(4): 1129 - 1142. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W. McNatt, I. McKittrick, M. West, and G. Odorizzi Direct Binding to Rsp5 Mediates Ubiquitin-independent Sorting of Sna3 via the Multivesicular Body Pathway Mol. Biol. Cell, February 1, 2007; 18(2): 697 - 706. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Kirk, L.-S. Chin, and L. Li GRIF1 binds Hrs and is a new regulator of endosomal trafficking J. Cell Sci., November 15, 2006; 119(22): 4689 - 4701. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Langelier, U. K. von Schwedler, R. D. Fisher, I. De Domenico, P. L. White, C. P. Hill, J. Kaplan, D. Ward, and W. I. Sundquist Human ESCRT-II Complex and Its Role in Human Immunodeficiency Virus Type 1 Release J. Virol., October 1, 2006; 80(19): 9465 - 9480. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Razi and C. E. Futter Distinct Roles for Tsg101 and Hrs in Multivesicular Body Formation and Inward Vesiculation Mol. Biol. Cell, August 1, 2006; 17(8): 3469 - 3483. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. O. Olabisi, G. M. Mahon, E. V. Kostenko, Z. Liu, H. L. Ozer, and I. P. Whitehead Bcr interacts with components of the endosomal sorting complex required for transport-I and is required for epidermal growth factor receptor turnover. Cancer Res., June 15, 2006; 66(12): 6250 - 6257. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. G. Bache, S. Stuffers, L. Malerod, T. Slagsvold, C. Raiborg, D. Lechardeur, S. Walchli, G. L. Lukacs, A. Brech, and H. Stenmark The ESCRT-III Subunit hVps24 Is Required for Degradation but Not Silencing of the Epidermal Growth Factor Receptor Mol. Biol. Cell, June 1, 2006; 17(6): 2513 - 2523. [Abstract] [Full Text] [PDF] |
||||